Ticker Scorecard - BHVN Basics Company: Biohaven Pharmaceutical Holding Company Ltd. IPO Date: May 11, 2017 Sector: Healthcare Industry: Biotech Market Cap: $3.62B Activated in VL: True Average Daily Range Avg Daily Range: $1.25 | 2.56% Avg Daily Range (30 D): $1.10 | 2.72% Avg Daily Range (90 D): $1.08 | 2.41% Institutional Daily Volume Avg Daily Volume: .7M Avg Daily Volume (30 D): .76M Avg Daily Volume (90 D): .84M Trade Size Avg Trade Size (Sh.): 79 Avg Trade Size (Sh.) (30 D): 59 Avg Trade Size (Sh.) (90 D): 63 Institutional Trades Total Inst.Trades: 4,925 Avg Inst. Trade: $3.15M Avg Inst. Trade (30 D): $2.94M Avg Inst. Trade (90 D): $2.86M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $5.04M Avg Closing Trade (30 D): $6.69M Avg Closing Trade (90 D): $6.3M Avg Closing Volume: 99.97K     News Jan 13, 2025 @ 1:04 AM Merus and Biohaven Announce Collaboration to Co-De... Source: N/A Sep 24, 2024 @ 7:08 PM BHVN Stock Up as Rare Neurological Disease Study M... Source: Zacks Jul 8, 2024 @ 9:21 AM Down 55%, Is Pfizer a Good Dividend Stock to Buy o... Source: Cory Renauer May 30, 2024 @ 3:29 PM Immunovant (IMVT) Falls as Q4 Earnings Miss, Pipel... Source: Zacks Equity Research May 29, 2024 @ 6:47 PM Biohaven Stock Stumbles As Protein-Degrading Drug ... Source: Vandana Singh Financials   TTM Q2 2024 Q1 2024 Basic EPS $-1.7 $-3.64 $-2.2 Diluted EPS $-1.7 $-3.64 $-2.2 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -160.3M $ -319.77M $ -179.5M Operating Income / Loss $ -178.17M $ -333.77M $ -183.24M Cost of Revenue $ $ $ Net Cash Flow $ -154.3M $ 55.39M $ -65.19M PE Ratio